Drugs / PF-06473871
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01753791 | Nov 2012 → Jun 2013 | — | Pfizer | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02205476 | Dec 2014 → Jan 2015 | keloid formation | Pfizer | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01730339 Comparator | Dec 2012 → Oct 2014 | keloid formation | Pfizer | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06473871 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01730339 ↗ |